Farletuzumab ecteribulin

HY-P99612
Product group Antibodies
Overview
- SupplierMedChem Express
- Product NameFarletuzumab ecteribulin
- Delivery Days Customer10
- CertificationResearch Use Only
- Estimated Purity98.10
- Scientific DescriptionFarletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.
- Storage Instruction-80°C
- UNSPSC12352203